3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Promyelocytic, Acute
3
Thrombocytopenia
2
Pathologic Complete Response
2
Multiple Myeloma
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Oligometastatic Disease
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Glioma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cisplatin
18
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Radiotherapy, Intensity-Modulated
7
Radiotherapy
7
Radiation
7
Carboplatin
7
Platinum
5
Chemoradiotherapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
Surgical Procedures, Operative
4
Paclitaxel
4
Docetaxel
4
Biopsy
4
pembrolizumab
3
Surveys and Questionnaires
3
toripalimab
2
aldesleukin
2
X-Rays
2
Taxes
2
Observation
2
Interviews as Topic
2
Immunohistochemistry
2
Cetuximab
2
Adoptive Transfer
2
sacituzumab govitecan
1
merphos
1
ipatasertib
1
human papillomavirus vaccine, TA
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Oropharyngeal Neoplasms
×
Tretinoin
×
Clear all
NCT06706401
2026-04-24
LYSARI
Centre Leon Berard
Phase 3
Recruiting
460 enrolled